Significance of persistence of antibodies against Leishmania infantum in sicilian patients affected by acute visceral leishmaniasis

Clinical and Experimental Medicine

Volumn 12, Issue 2, 2012, Pages 127-132

  Mansueto, Pasquale ^a   Pepe, Ilenia ^a   Seidita, Aurelio ^a   Scozzari, Francesca ^a   Vitale, Giustina ^a   Arcoleo, Francesco ^b   Elvira, Inglese ^b   Cillari, Enrico ^b   Rini, Giovam Battista ^a   Napoli, Nicola ^c   Di Rosa, Salvatore ^b   Mansueto, Serafino ^a   Di Fede, Gaetana ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Azienda Ospedaliera Ospedali Riuniti 'Villa Sofia Cervello'   (Italy)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

Kinetic of antibodies; L. infantum; Persistence of antibodies; Visceral leishmaniasis; VL relapse; VL resistance

Indexed keywords

AMPHOTERICIN B; IMMUNOGLOBULIN G ANTIBODY; MEGLUMINE ANTIMONATE;

ADULT; ANEMIA; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BONE MARROW BIOPSY; FEMALE; FEVER; HEPATOSPLENOMEGALY; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNOCOMPETENCE; IMMUNOFLUORESCENCE TEST; ITALY; LEISHMANIA INFANTUM; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PALLOR; PRIORITY JOURNAL; PROGNOSIS; RECURRENT INFECTION; THERAPY RESISTANCE; THROMBOCYTOPENIA; TREATMENT RESPONSE; VISCERAL LEISHMANIASIS; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, PROTOZOAN; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOGLOBULIN G; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; RECURRENCE; SICILY; TIME FACTORS; YOUNG ADULT;

LEISHMANIA INFANTUM;

EID: 84861481799     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-011-0150-9     Document Type: Article

References (27)

1. Dujardin JC, Campino L, Cañavate C, Dedet JP, Gradoni L, Soteriadou K, Mazeris A, Ozbel Y, Boelaert M (2008) Spread of vector-borne diseases and neglect of Leishmaniasis. Europe Emerg Infect Dis 14(7):1013-1018 (Pubitemid 351920428)
2. http://www.istat.it/sanita/Health
3. Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW, Alvar J, Boelaert M (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 5(11):873-882 (Pubitemid 47578388)
4. Mansueto P, Vitale G, Di Lorenzo G, Rini GB, Mansueto S, Cillari E (2007) Immunopathology of leishmaniasis: an update. Int J Immunopathol Pharmacol 20(3):435-445 (Pubitemid 47531048)
5. Anam K, Afrin F, Banerjee D, Pramanik N, Guha SK, Goswami RP, Gupta PN, Saha SK, Ali N (1999) Immunoglobulin subclass distribution and diagnostic value of Leishmania donovani antigen-specific immunoglobulin G3 in Indian kala-azar patients. Clin Diagn Lab Immunol 6:231-235 (Pubitemid 29124970)
6. Da Matta VL, Hoshino-Shimizu S, Dietze R, Corbett CE (2000) Detection of specific antibody isotypes and subtypes before and after treatment of American visceral leishmaniasis. J Clin Lab Anal 14:5-12 (Pubitemid 30085777)
7. Cascio G (1970) Behavior of antibodies (titrated by means of the immunofluorescence test) in visceral leishmaniasis treated by antimony therapy. Pediatria 78(3):497-504
8. Avila JL, Rojas M, GarcíaL (1998) Persistence of elevated levels of galactosyl-alpha(1-3)galactose antibodies in sera from patients cured of visceral leishmaniasis. J Clin Microbiol 26(9):1842-1847
9. De Almeida Silva L, Romero HD, Prata A, Costa RT, Nascimento E, Carvalho SF, Rodrigues V (2006) Immunologic tests in patients after clinical cure of visceral leishmaniasis. Am J Trop Med Hyg 75(4):739-743 (Pubitemid 46941286)
10. Hailu A (1990) Pre- and post-treatment antibody levels in visceral leishmaniasis. Trans R Soc Trop Med Hyg 84(5):673-675
11. Londner MV, Feinsod FM, Faris R, Rosen G, el Said S, Saah AJ (1988) Persistence of human leishmanial antibodies in an endemic area of visceral leishmaniasis in El Agamy, Egypt. Eur J Epidemiol 4(4):473-476 (Pubitemid 19016123)
12. Musa AM, Khalil EA, Raheem MA, Zijlstra EE, Ibrahim ME, Elhassan IM, Mukhtar MM, El Hassan AM (2002) The natural history of Sudanese post-kala-azar dermal leishmaniasis: clinical, immunological and prognostic features. Ann Trop Med Parasitol 96(8):765-772 (Pubitemid 36152844)
13. Mokrani T, Belazzoug S, Bouzid Z, Keddari M (1988) Development of antibodies in children treated for visceral leishmaniasis. Arch Inst Pasteur Alger 56:101-107
14. Cascio A, Colomba C, Antinori S, Orobello M, Paterson D, Titone L (2002) Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases. Eur J Clin Microbiol Infect Dis 21(4):277-282 (Pubitemid 34507872)
15. Pasquau F, Ena J, Sanchez R, Cuadrado JM, Amador C, Flores J, Benito C, Redondo C, Lacruz J, Abril V, Onofre J (2005) Leishmania HIV Mediterreanean Co-operative Group. Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region. Eur J Clin Microbiol Infect Dis 24(6):411-418 (Pubitemid 40933916)
16. Leishmania/HIV co-infection, south-western Europe, 1990-1998 (1999) Wkly Epidemiol Rec 74:365-375
17. Mansueto S, Vitale G, Miceli MD, Montaperto B, Alberti L, Quartararo P (1982) Valutazione di quattro tests (latex-agglutinazione, controimmunoelettroforesi, emoagglutinazione indiretta ed ELISA) nella diagnostica della Leishmaniosi umana. Acta Medit Patol Inf Trop 1(S):75-85
18. Mansueto S, Vitale G, Mocciaro C, Librizzi R, Friscia I, Usticano V, Gambino G, Reina G (1989) Laboratory diagnosis of boutonneuse fever by enzyme-linked immunosorbent assay. Trans R Soc Trop Med Hyg 83(6):855-857 (Pubitemid 20004511)
19. Alvar J, Aparicio P, Aseffa A, Den Boer M, Cañavate C, Dedet JP, Gradoni L, Ter Horst R, López-Vélez R, Moreno J (2008) The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 21(2):334-359 (Pubitemid 351555511)
20. Bern C, Jha SN, Joshi AB, Thakur GD, Bista MB (2000) Use of the recombinant K39 dipstick test and the direct agglutination test in a setting endemic for visceral leishmaniasis in Nepal. Am J Trop Med Hyg 63(3-4):153-157 (Pubitemid 32488353)
21. Kaul P, Malla N, Kaur S, Mahajan RC, Ganguly NK (2000) Evaluation of a 200-kDa amastigote-specific antigen of L. donovani by enzyme-linked immunosorbent (ELISA) for the diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg 94(2):173-175 (Pubitemid 30307288)
22. Singh S, Gilman-Sachs A, Chang KP, Reed SG (1995) Diagnostic and prognostic value of K39 recombinant antigen in Indian leishmaniasis. J Parasitol 81(6):1000-1003 (Pubitemid 26018413)
23. Singh S, Kumari V, Singh N (2002) Predicting kala-azar disease manifestation in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant k39 antigen. Clin Diagn Lab Immunol 9(3):568-572 (Pubitemid 34538215)
24. Singh S, Sivakumar R (2003) Recent advances in the diagnosis of leishmaniasis. J Postgrad Med 49(1):55-66
25. Sundar S, Rai M (2002) Laboratory diagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol 9(5):951-958 (Pubitemid 34988459)
26. Houghton RL, Petrescu M, Benson DR, Skeiky YA, Scalone A, Badaró R, Reed SG, Gradoni L (1998) A cloned antigen (recombinant K39) of Leishmania chagasi diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug therapy. J Infect Dis 177(5):1339-1344 (Pubitemid 28194276)
27. Cleveland WS (1993) Visualizing data. At & T Bell Laboratories, Murray Hill